PMC:7546122 / 6919-7427
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T32","span":{"begin":36,"end":46},"obj":"Body_part"},{"id":"T33","span":{"begin":381,"end":386},"obj":"Body_part"}],"attributes":[{"id":"A32","pred":"fma_id","subj":"T32","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A33","pred":"fma_id","subj":"T33","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Detection of HCoV-229E Neutralizing Antibodies\nThe neutralization assay for HCoV-229E antibodies is essentially identical to the SARS-CoV-2, where samples were used undiluted or prediluted, then serially diluted in 2-fold steps and mixed 1:2 with 103.0 TCID50/mL HCoV-229E (Cat. no. VR-740, American Type Culture Collection [ATCC], Rockville, MD), incubated, and titrated on MRC-5 cells (Cat. no. CCL-171, ATCC, Rockville, MD). The virus-induced cytopathic effect was determined after 7–9 days of incubation."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T30","span":{"begin":129,"end":137},"obj":"Disease"}],"attributes":[{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Detection of HCoV-229E Neutralizing Antibodies\nThe neutralization assay for HCoV-229E antibodies is essentially identical to the SARS-CoV-2, where samples were used undiluted or prediluted, then serially diluted in 2-fold steps and mixed 1:2 with 103.0 TCID50/mL HCoV-229E (Cat. no. VR-740, American Type Culture Collection [ATCC], Rockville, MD), incubated, and titrated on MRC-5 cells (Cat. no. CCL-171, ATCC, Rockville, MD). The virus-induced cytopathic effect was determined after 7–9 days of incubation."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T63","span":{"begin":343,"end":345},"obj":"http://purl.obolibrary.org/obo/CLO_0007622"},{"id":"T64","span":{"begin":375,"end":386},"obj":"http://purl.obolibrary.org/obo/CLO_0052043"},{"id":"T65","span":{"begin":375,"end":386},"obj":"http://purl.obolibrary.org/obo/CLO_0052044"},{"id":"T66","span":{"begin":375,"end":386},"obj":"http://purl.obolibrary.org/obo/CLO_0052045"},{"id":"T67","span":{"begin":423,"end":425},"obj":"http://purl.obolibrary.org/obo/CLO_0007622"},{"id":"T68","span":{"begin":432,"end":437},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Detection of HCoV-229E Neutralizing Antibodies\nThe neutralization assay for HCoV-229E antibodies is essentially identical to the SARS-CoV-2, where samples were used undiluted or prediluted, then serially diluted in 2-fold steps and mixed 1:2 with 103.0 TCID50/mL HCoV-229E (Cat. no. VR-740, American Type Culture Collection [ATCC], Rockville, MD), incubated, and titrated on MRC-5 cells (Cat. no. CCL-171, ATCC, Rockville, MD). The virus-induced cytopathic effect was determined after 7–9 days of incubation."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T43","span":{"begin":0,"end":46},"obj":"Sentence"},{"id":"T44","span":{"begin":47,"end":282},"obj":"Sentence"},{"id":"T45","span":{"begin":283,"end":396},"obj":"Sentence"},{"id":"T46","span":{"begin":397,"end":427},"obj":"Sentence"},{"id":"T47","span":{"begin":428,"end":508},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Detection of HCoV-229E Neutralizing Antibodies\nThe neutralization assay for HCoV-229E antibodies is essentially identical to the SARS-CoV-2, where samples were used undiluted or prediluted, then serially diluted in 2-fold steps and mixed 1:2 with 103.0 TCID50/mL HCoV-229E (Cat. no. VR-740, American Type Culture Collection [ATCC], Rockville, MD), incubated, and titrated on MRC-5 cells (Cat. no. CCL-171, ATCC, Rockville, MD). The virus-induced cytopathic effect was determined after 7–9 days of incubation."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"119","span":{"begin":13,"end":22},"obj":"Species"},{"id":"126","span":{"begin":274,"end":277},"obj":"Gene"},{"id":"127","span":{"begin":388,"end":391},"obj":"Gene"},{"id":"128","span":{"begin":129,"end":139},"obj":"Species"},{"id":"129","span":{"begin":263,"end":272},"obj":"Species"},{"id":"130","span":{"begin":76,"end":85},"obj":"Species"},{"id":"131","span":{"begin":375,"end":380},"obj":"CellLine"}],"attributes":[{"id":"A119","pred":"tao:has_database_id","subj":"119","obj":"Tax:11137"},{"id":"A126","pred":"tao:has_database_id","subj":"126","obj":"Gene:847"},{"id":"A127","pred":"tao:has_database_id","subj":"127","obj":"Gene:847"},{"id":"A128","pred":"tao:has_database_id","subj":"128","obj":"Tax:2697049"},{"id":"A129","pred":"tao:has_database_id","subj":"129","obj":"Tax:11137"},{"id":"A130","pred":"tao:has_database_id","subj":"130","obj":"Tax:11137"},{"id":"A131","pred":"tao:has_database_id","subj":"131","obj":"CVCL:0440"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Detection of HCoV-229E Neutralizing Antibodies\nThe neutralization assay for HCoV-229E antibodies is essentially identical to the SARS-CoV-2, where samples were used undiluted or prediluted, then serially diluted in 2-fold steps and mixed 1:2 with 103.0 TCID50/mL HCoV-229E (Cat. no. VR-740, American Type Culture Collection [ATCC], Rockville, MD), incubated, and titrated on MRC-5 cells (Cat. no. CCL-171, ATCC, Rockville, MD). The virus-induced cytopathic effect was determined after 7–9 days of incubation."}